Your browser doesn't support javascript.
loading
J-shaped association between LDL cholesterol and cardiovascular events: A longitudinal primary prevention cohort of over 2.4 million people nationwide.
Park, Chan Soon; Yang, Han-Mo; Han, Kyungdo; Lee, Hee-Sun; Kang, Jeehoon; Han, Jung-Kyu; Park, Kyung Woo; Kang, Hyun-Jae; Koo, Bon-Kwon; Kim, Hyo-Soo.
Affiliation
  • Park CS; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Yang HM; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: hanname@hanmail.net.
  • Han K; Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea. Electronic address: hkd0917@naver.com.
  • Lee HS; Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Republic of Korea.
  • Kang J; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Han JK; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Park KW; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Kang HJ; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Koo BK; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Kim HS; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
J Adv Res ; 58: 139-147, 2024 Apr.
Article de En | MEDLINE | ID: mdl-37225014
ABSTRACT

INTRODUCTION:

Low-density lipoprotein (LDL) cholesterol-lowering treatment is beneficial for the secondary or primary prevention of high-risk atherosclerotic cardiovascular disease (ASCVD). However, the prognostic implications of low LDL cholesterol levels in patients without previous ASCVD and without statin use remain elusive.

METHODS:

From a nationwide cohort, 2,432,471 participants without previous ASCVD or statin use were included. For myocardial infarction (MI) and ischemic stroke (IS), participants were followed-up from 2009 to 2018. They were stratified according to 10-year ASCVD risk (<5 %, 5 %-<7.5 %, 7.5 %-<20 %, and ≥20 %) and LDL cholesterol level (<70, 70-99, 100-129, 130-159, 160-189, and ≥190 mg/dL).

RESULTS:

The relationship between LDL cholesterol levels and ASCVD events exhibited a J-shaped curve for both MI and IS. After classification according to the ASCVD risk, this J-shaped relationship was consistently observed for the composite of MI and IS. Participants with an LDL cholesterol level <70 mg/dL showed a higher MI risk than those with a level of 70-99 mg/dL or 100-129 mg/dL in the low-ASCVD risk group. The J-shaped curve between LDL cholesterol levels and MI risk was attenuated across ASCVD risk groups. For IS, participants with an LDL cholesterol level <70 mg/dL demonstrated increased risks compared with those with a level of 70-99 mg/dL, 100-129 mg/dL, or 130-159 mg/dL in the borderline, intermediate, and high ASCVD risk groups, respectively. In contrast, a linear association was observed in participants taking statins. Interestingly, a J-shaped association was observed between LDL cholesterol and high-sensitivity C-reactive protein (hs-CRP) levels; the mean hs-CRP level and the proportion of individuals with increased hs-CRP levels were relatively high among individuals with an LDL cholesterol level <70 mg/dL.

CONCLUSIONS:

Although high LDL cholesterol levels increase the risk of ASCVD, low LDL cholesterol levels do not warrant safety from ASCVD. Therefore, individuals with low LDL cholesterol levels should be carefully monitored.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Inhibiteurs de l&apos;hydroxyméthylglutaryl-CoA réductase / Athérosclérose / Infarctus du myocarde Type d'étude: Risk_factors_studies Limites: Humans Langue: En Journal: J Adv Res Année: 2024 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Inhibiteurs de l&apos;hydroxyméthylglutaryl-CoA réductase / Athérosclérose / Infarctus du myocarde Type d'étude: Risk_factors_studies Limites: Humans Langue: En Journal: J Adv Res Année: 2024 Type de document: Article